-
1
-
-
0020320280
-
Studies on the biological between thromboxanes and prostacyclins in relation to the platelet-vessel wall interaction
-
Jorgensen KA. Studies on the biological between thromboxanes and prostacyclins in relation to the platelet-vessel wall interaction. Dan Med Bull. 1982;29:169-97.
-
(1982)
Dan Med Bull.
, vol.29
, pp. 169-197
-
-
Jorgensen, K.A.1
-
3
-
-
0028283508
-
Hirudin: Clinical potential of a thrombin inhibitor
-
Johnson PH. Hirudin: clinical potential of a thrombin inhibitor. Ann Rev Med. 1994;45:165-177.
-
(1994)
Ann Rev Med.
, vol.45
, pp. 165-177
-
-
Johnson, P.H.1
-
4
-
-
0024471870
-
Ancrod (Arvin®) as an alternative to heparin anticoagulation for cardiopulmonary bypass
-
Zulys VJ, Teasdale SJ, Michel ER, et al. Ancrod (Arvin®) as an alternative to heparin anticoagulation for cardiopulmonary bypass. Anesthesiology. 1989;71:870-877.
-
(1989)
Anesthesiology
, vol.71
, pp. 870-877
-
-
Zulys, V.J.1
Teasdale, S.J.2
Michel, E.R.3
-
5
-
-
0025301187
-
Intraoperative management of patients with heparin-induced thrombocytopenia
-
Kappa JR, Fisher CA, Todd B, et al. Intraoperative management of patients with heparin-induced thrombocytopenia. Ann Thorac Surg. 1990;49:714-723.
-
(1990)
Ann Thorac Surg.
, vol.49
, pp. 714-723
-
-
Kappa, J.R.1
Fisher, C.A.2
Todd, B.3
-
6
-
-
0021133327
-
Comparison of the effect of a conventional heparin and a low molecular weight heparinoid on platelet function
-
Mikhailidis DP, Barrados MA, Mikhailidis AM, et al. Comparison of the effect of a conventional heparin and a low molecular weight heparinoid on platelet function. Br J Clin Pharmacol. 1984;17:43-8.
-
(1984)
Br J Clin Pharmacol.
, vol.17
, pp. 43-48
-
-
Mikhailidis, D.P.1
Barrados, M.A.2
Mikhailidis, A.M.3
-
7
-
-
0026559574
-
Cardiopulmonary bypass with low-molecular-weight heparin fraction (enoxaparin) in a patient with a history of heparin-associated thrombocytopenia
-
Robitaille D, LeClerc JR, Laberge R, et al. Cardiopulmonary bypass with low-molecular-weight heparin fraction (enoxaparin) in a patient with a history of heparin-associated thrombocytopenia. J Thorac Cardiovasc Surg. 1992;103:597-99.
-
(1992)
J Thorac Cardiovasc Surg.
, vol.103
, pp. 597-599
-
-
Robitaille, D.1
LeClerc, J.R.2
Laberge, R.3
-
8
-
-
0024460872
-
Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis
-
Teasdale SJ, Zulys VJ, Mycyk T, et al. Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis. Ann Thorac Surg. 1989;48:712-3.
-
(1989)
Ann Thorac Surg.
, vol.48
, pp. 712-713
-
-
Teasdale, S.J.1
Zulys, V.J.2
Mycyk, T.3
-
9
-
-
0025040152
-
"Heparin-free" cardiopulmonary bypass: First reported use of heparinoid (Org10172) to provide anticoagulation for cardiopulmonary bypass
-
Doherty DC, Ortel TL, De Bruijn N, et al. "Heparin-free" cardiopulmonary bypass: first reported use of heparinoid (Org10172) to provide anticoagulation for cardiopulmonary bypass. Anesthesiology. 1990;73:562.
-
(1990)
Anesthesiology
, vol.73
, pp. 562
-
-
Doherty, D.C.1
Ortel, T.L.2
De Bruijn, N.3
|